70th Society for Social Medicine & Population Health Conference & European Congress of Epidemiology 20269-11 September 2026, Queen Mary University of London Mile End Campus. Organised by the Society for Social Medicine & Population Health & the International Epidemiological Association
People sat clapping
Person giving presentation to an audience
People sat talking in an old ballroom
Want to know what to expect at SSM EuroEpi 2026?
See our blogs recapping Bradford's #SSM2025: bit.ly/452ATDW
Just 1 (scientifically) chosen quote from an attendee: "brilliant opportunity to meet colleagues working across public health, & hear inspiring + informative talks about important research"
12.12.2025 09:19 — 👍 1 🔁 1 💬 0 📌 0
Thank you to @jclinepi.bsky.social for the opportunity to join the team! Look forward to learning from and working with everyone!
21.04.2025 13:50 — 👍 1 🔁 0 💬 0 📌 0
So, if you see any that named me as a speaker, this is without my consent / knowledge. I would advise against registering for it. I would also advise my fellow colleagues, especially those in academia, to be vigilant on potential misuse of their names. Thank you.
10.04.2025 13:25 — 👍 0 🔁 0 💬 0 📌 0
A kind colleague has alerted me that I have been "named" as a speaker in an upcoming public health conference scheduled to be held in February 2026. I would like to clarify that I have not agreed to speak at any conference in 2026.
10.04.2025 13:25 — 👍 1 🔁 1 💬 2 📌 0
<50% EEs reported intervals,diagnostic method, treatment & screening locations. None reported all aspects of screening designs.
We recommend future EEs of T2DM screening to report all aspects of screening designs, to allow synthesis and assessment of findings transferability.
27.02.2025 21:52 — 👍 0 🔁 0 💬 0 📌 0
Limitations:
(1) These observations are generalisations of multiple screening designs e.g., screening programme of different screening intervals, screening locations, etc.
(2) Some comparisons were contributed by single EEs.
27.02.2025 21:52 — 👍 0 🔁 0 💬 1 📌 0
Compared to universal screening, targeted screening (e.g., among obese) may be cost-effectv or dominant.
Similarly for expanding screening locations, or ⬇️FPG / HbA1c thresholds (but not too ⬇️) for diagnosis.
27.02.2025 21:52 — 👍 0 🔁 0 💬 1 📌 0
Compared to no screening,
(a) screening with biomarkers not cost-effective in ~half EEs (23/54 comparisons),
(b) screening with risk score alone mostly dominant (6/10),
(c) screening with combinations of risk score and biomarkers cost-effectv (21/40) or dominant (19/40).
27.02.2025 21:52 — 👍 0 🔁 0 💬 1 📌 0
We identified T2DM screening designs based on the
(a) screening tool (single biomarker, multiple biomarkers, risk scores or combinations),
(b) screening intervals,
(c) minimum age for screening,
(d) location,
(e) diagnosis method and
(f) treatment
27.02.2025 21:52 — 👍 0 🔁 0 💬 1 📌 0
Redirecting
In our latest work, we reviewed recent economic evaluations (EEs) of screening for type 2 diabetes mellitus (T2DM) according to the comparators and screening designs.
doi.org/10.1016/j.jv...
We highlight our findings in this thread.
27.02.2025 21:52 — 👍 1 🔁 0 💬 1 📌 0
Shifting Gears: Navigating Career Transitions Across Sectors – International Health Economics Association
Online panel on transitioning across sectors for early-career health economists, 3 Feb (Mon) 9am GMT. Featuring 3 health economists from Aus, UK & NL who shifted from academia to industry, gov, non-profit, consultancy and pharma.
healtheconomics.org/event/shifti...
www.linkedin.com/posts/health...
29.01.2025 12:57 — 👍 0 🔁 0 💬 1 📌 0
Co-Creating Ireland's Public Involvement in Open Research Roadmap
ENGAGED is building a national roadmap to shape public involvement in open research in Ireland. We believe that research can and does play an important role in tackling societal challenges.
Data viz, and all that jazz
Advancing knowledge for population health https://socsocmed.org.uk/member-registration/
Senior reporter at MIT Technology Review. Previously at New Scientist. Knight Science Journalism fellow '24. Health, biomed and biotech. She/her. Signal: jess_hamzelou.01
Supporting the uptake and integration of evidence-based interventions into health and public health systems.
Medical statistician and Director of PCTU, mum and reader of just about anything I can get my hands on (preferably whilst drinking tea and eating cake)
News and views from from King's Health Economics (KHE) research group at Institute of Psychiatry, Psychology and Neuroscience at King's College London
Health scientist / epidemiologist with an interest in cancer survivorship research and causal inference methods
Co-Editor, Journal of Clinical Epidemiology
Emeritus Editor in Chief, Cochrane
Newish grandparent, run and cycle a bit.
Prof of Epidemiology at University Paris Cité
Director of the Centre for Research in Epidemiology and Statistics (CRESS)
Head of the METHODS team within the CRESS
Director of Cochrane France
A Professor in family medicine and a leader in evidence-based healthcare (HC). As one of the first female MPs in Saudi Arabia’s Shura Council & the first Arab WHO Assistant Director-General, I continue to shape HC through academia and patient care.
Meta-meta-meta researcher in systematic reviews. Research integrity, research culture and other human influences in research. Senior Research Fellow at University of Sheffield.
ORCID ID: 0000-0003-4603-9069
Executive Director & Tier 1 Canada Research Chair, Li Ka Shing Knowledge Institute; Full Professor, University of Toronto; Co-Editor in Chief, Journal of Clinical Epidemiology
Publisher at Elsevier with journals in the health and medical sciences. Views my own.
OHE is a global thought leader and publisher in the economics of health, health care and life sciences. Our work informs decision-making globally.
Health economist @ Macquarie University Centre for the Health Economy in Australia. Interested in HTA, pharmaceutical policy, diagnostics, genomics, cancer, hearing health. Wannabe painter, sometimes gardener, occasional hiker, cat lover. Views are my own.
Senior Research Fellow (@muche-macquarie.bsky.social). PhD in economics and health policy. Running. Caffeine. Any opinions expressed are wholly my own. My website: https://sites.google.com/mq.edu.au/anambilgrami/home
Health Economics Research Centre | University of Oxford | Research, publications, courses, jobs, seminars | https://www.herc.ox.ac.uk/
Our vision is to create a world where decision makers are empowered with applied, trusted and influential research into health and human services policy and systems. https://www.linkedin.com/company/macquarie-university-centre-for-the-health-economy/
